3. Balachandar S, La Quaglia M, Tuttle RM, Heller G, Ghossein RA, Sklar CA. Pediatric
differentiated thyroid carcinoma of follicular cell origin: prognostic significance of histologic …

Differentiated thyroid cancer is a fascinating disease—it is both frustrating and heartening to
treat. As eloquently pointed out by Tuttle in this issue of The Journal of Nuclear Medicine …

Thyroid cancer is very rare in children. 131 I therapy after thyroidectomy is established in
pediatric differentiated thyroid cancer (DTC). Pediatric DTC guideline is silent on the …

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of
optimizing outcomes. This principle is being applied to radioactive iodine therapy …

Purpose The purpose of the following commentary is to discuss recent controversies in the
use of radioactive iodine for differentiated thyroid cancer (DTC). Methods RM Tuttle (Thyroid …

Objectives To compare the ablation results, therapeutic responses and adverse reactions
between a low dose (1.1 GBq) or high dose (3.7 GBq) of 131 I in low-/intermediate-risk …

Radioiodine therapy is a matter of controversy because different opinions exist about its use
for differentiated thyroid carcinoma. The following article sheds light on the different opinions …

TO THE EDITOR: We read with interest the article by Deandreis et al.(1) that compared a
fixed-activity approach to radioiodine treatment of metastatic differentiated thyroid cancer …

The World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) is a
worldwide nonprofit organization, which is dedicated to educating medical professionals in …

In the adult population, the differentiated thyroid cancer (DTC) is the most frequent
endocrine neoplasm [1]. According to the American Thyroid Association (ATA) guidelines, in …